
TMS is a non-invasive treatment that uses magnetic fields to stimulate nerve cells in the brain. It is often used to treat depression, especially when other treatments, such as medications or therapy, have not been effective.
This is a Health Canada-approved treatment.
Minutes per session

Weeks of treatment

Number of session
No, TMS is a non-invasive procedure that does not require anesthesia. Patients remain awake during the treatment, which is performed in a clinic setting.
TMS is effective about 75% of the time, making it twice as effective as antidepressant medications and nearly as effective as electroconvulsive therapy (ECT). Nearly half of those who respond to TMS experience improvement within the first few weeks of treatment.
TMS is typically prescribed when antidepressants have failed or when their side effects are intolerable. Unlike antidepressants, which are systemic and absorbed into the bloodstream, TMS is non-invasive and has no systemic side effects.
TMS is recommended for individuals who have not found relief from depression through medications or psychotherapy, or for those who wish to avoid medication side effects, such as sexual dysfunction and weight gain.
TMS is performed in a clinic, where you will sit in a comfortable chair. The doctor will position a magnetic coil on your head, and you may feel a moderate tapping sensation during the procedure. You will remain awake and alert, and after the session, you can drive home and resume normal activities.
During TMS treatment, you will hear a clicking sound and feel a tapping sensation on your head as the magnetic pulses are delivered. The sensation is generally well-tolerated, and no anesthesia is needed.
TMS sessions last between 3 and 37.5 minutes and are typically conducted 5 days a week for about six weeks. Your treatment schedule will be customized based on your specific needs.
TMS is generally safe and well-tolerated, with the most common side effects being mild to moderate scalp discomfort and mild headaches, both of which are short-term. There is a rare risk of seizure (less than 0.1%), but these are typically self-limiting and transient.
Most insurance providers cover TMS, but prior authorization is usually required. Your physician will help you with this process to ensure insurance coverage for the treatment.
We aim to schedule intake assessments within 1 to 2 weeks for treatment-resistant depression. Following the assessment, treatment typically begins within a week. Wait times may vary depending on demand, but we strive to accommodate patients as quickly as possible.